4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001415889-25-001162
Options or other derivatives
- Director acquired 47,587 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Lamond David Director | 2025-01-02 | Grant or award · Director Stock Option (right to buy) | +47,587 | 47,587 | D: show line 1 in the form |
Loading xslF345X05/form4-01092025_120154.xml…